FDA Panel Backs New Melanoma Treatment After 2 Rejections

A promising viral cancer therapy just cleared a major hurdle, giving new hope to advanced melanoma patients.

After two rejections, an FDA expert panel voted 10-3 to recommend Replimune's innovative treatment for review.